Epigallocatechin Gallate Reduces Ischemia/Reperfusion Injury in Isolated Perfused Rabbit Hearts

International Journal of Molecular Sciences
Aida SalamehStefan Dhein

Abstract

Cardioplegic arrest during heart operations is often used in cardiac surgery. During cardioplegia, the heart is subjected to a global ischemia/reperfusion-injury. (-)-epigallocatechin gallate (EGCG), one of the main ingredients of green tea, seems to be beneficial in various cardiac diseases. Therefore, the aim of our study was to evaluate EGCG in a rabbit model of cardioplegic arrest. Twenty four mature Chinchilla rabbits were examined. Rabbit hearts were isolated and perfused according to Langendorff. After induction of cardioplegia (without and with 20 µmol/L EGCG, n = 6 each) the hearts maintained arrested for 90-min. Thereafter, the hearts were re-perfused for 60 min. During the entire experiment hemodynamic and functional data were assessed. At the end of each experiment, left ventricular samples were processed for ATP measurements and for histological analysis. Directly after cessation of cardioplegia, all hearts showed the same decline in systolic and diastolic function. However, hearts of the EGCG-group showed a significantly faster and better hemodynamic recovery during reperfusion. In addition, tissue ATP-levels were significantly higher in the EGCG-treated hearts. Histological analysis revealed that markers of nitro...Continue Reading

References

May 1, 1992·Preventive Medicine·H N Graham
Mar 1, 1986·The American Journal of Physiology·G J GrossD C Warltier
Apr 27, 2002·The American Journal of Clinical Nutrition·Johanna M GeleijnseJacqueline C M Witteman
May 30, 2002·Circulation·Kenneth J MukamalMurray A Mittleman
Nov 9, 2002·The American Journal of Cardiology·Reiko HiranoFumitaka Ohsuzu
Sep 10, 2003·Biochemical and Biophysical Research Communications·Gi-Tae KimMyung-Suk Kim
Aug 21, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Paul A TownsendAnastasis Stephanou
Sep 14, 2006·JAMA : the Journal of the American Medical Association·Shinichi KuriyamaIchiro Tsuji
Jan 19, 2007·Journal of the American College of Nutrition·Kenneth J MukamalMurray A Mittleman
Jun 23, 2007·Cardiovascular & Hematological Disorders Drug Targets·George L TipoeMan-Lung Fung
May 6, 2008·Archives of Biochemistry and Biophysics·Ana OlmosSalvador Máñez
May 21, 2010·The Journal of Pharmacology and Experimental Therapeutics·Jiesheng KangDavid Rampe
Jun 16, 2010·The Journal of Thoracic and Cardiovascular Surgery·Shigeki YanagiRyuzo Sakata
Dec 1, 2011·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Cheng Shi PiaoSoo-Wan Chae
Oct 30, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Miriam TwalStefan Dhein
Mar 2, 2013·Current Pharmaceutical Design·Naghma Khan, Hasan Mukhtar
Sep 4, 2015·Clinical and Experimental Pharmacology & Physiology·Aida SalamehStefan Dhein
Dec 18, 2015·The Annals of Thoracic Surgery·Masaki FunamotoRyuzo Sakata
Mar 30, 2016·The Journal of Surgical Research·Bernhard KasperStefan Dhein

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear translocation

Software Mentioned

Systat

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.